Distribution of opioid peptide receptors in muscles of lean and obese-diabetic mice

Peptides

Volumn 17, Issue 4, 1996, Pages 629-634

  Evans, Anthony A L ^a   Smith, Margaret E ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Endorphin; DPDPE; EDL; Neuromuscular junction; Opioid receptor; Skeletal muscle; Soleus; Type II diabetes mellitus

Indexed keywords

BETA ENDORPHIN; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; MALE; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BINDING; SOLEUS MUSCLE;

ANIMALIA;

EID: 0029948508     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00068-X     Document Type: Article

References (26)

1. 1. Bailey, C. J.; Flatt, P. R. Increased responsiveness to glucoregulatory effect of opiates in obese-diabetic ob/ob mice. Diabetologia 30:33-37; 1987.
2. 2. Eadie, G. S. The inhibition of cholinesterase by morphine in vitro. J. Biol. Chem. 138:597-602; 1941.
3. 3. Evans, A. A. L.; Hughes, S.; Smith, M. E. Delta-opioid peptide receptors in muscles from obese-diabetic and normal mice. Peptides 16(2):361-364; 1995.
4. 4. Evans, A. A. L.; Smith, M. E. Opioid receptors in fast and slow skeletal muscles of lean and obese-diabetic mice in vitro. J. Physiol. (Lond.) 483:78P-79P; 1995.
5. 5. Evans, A. A. L.; Smith, M. E. β-Endorphin receptors at the neuromuscular junction in the mouse in vitro. J. Physiol. (Lond.) 487:162P-163P; 1995.
6. 6. Haynes, L. W.; Smith, M. E. Selective inhibition of "motor-endplate specific" acetylcholinesterase by β-endorphin and related peptides. Neuroscience 7(4):1007-1013; 1982.
7. 7. Haynes, L. W.; Smith, M. E. Release of β-endorphin from the motor nerve of the immature rat. J. Physiol. 351:22P; 1984.
8. 8. Haynes, L. W.; Smith, M. E. Presence of immunoreactive α-melanotropin and β-endorphin in spinal motoneurones of the dystrophic mouse. Neurosci. Lett. 58:13-18; 1985.
9. 9. Haynes, L. W.; Smith, M. E.; Smyth, D. G. Evidence for the neurotrophic regulation of collagen-tailed acetylcholinesterase in immature skeletal muscle by β-endorphin. J. Neurochem. 42(6):1542-1551; 1984.
10. 10. Henriksen, E. J.; Bourey, R. E.; Rodnick, K. J.; Koranyi, L.; Permutt, M. A.; Holloszy, J. O. Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am. J. Physiol. 259:E593-E598; 1990.
11. 11. Herkenham, M ; Pert, C. B. Light microscopic localization of brain opiate receptors: A general autoradiographic method which preserves tissue quality. J. Neurosci. 2(8):1129-1149; 1982.
12. 12. Hughes, S.; Smith, M. E. Opioid receptors in skeletal muscle of normal and dystrophic mice. Neurosci. Lett. 116:29-33; 1990.
13. 13. Hughes, S.; Smith, M. E. Proopiomelanocortin-derived peptides in mice with motoneurone disease. Neurosci. Lett. 103:169-173; 1989.
14. 14. Hughes, S.; Smith, M. E.; Bailey, C. J. β-Endorphin and corticotropin immunoreactivity and specific binding in the neuromuscular system of obese-diabetic mice. Neuroscience 48(2):463-468; 1992.
15. 15. Hughes, S.; Smith, M. E.; Bailey, C. J. POMC-derived peptides in the neuromuscular system of streptozotocin-diabetic mice. Peptides 13:873-877; 1992.
16. 16. James, D. E.; Jenkins, A. B.; Kraegen, E. W. Heterogeneity of insulin action in individual muscles in vivo: Euglycemic clamp studies in rats. Am. J. Physiol. 248:E567-E574; 1985.
17. 17. Jeal, S.; Turner, S.; Smith, M. E.; Bailey, C. J. Effect of β-endorphin on glucose uptake in insulin-resistant muscles of obese-diabetic (ob/ ob) mice. J. Physiol. (in press).
18. 18. Kern, M.; Wells, J. A.; Stephens, J. M.; Elton, C. W ; Friedman, J. E. Insulin responsiveness in skeletal muscle is determined by glucose transporter (GLUT 4) protein level. Biochem. J. 270:397-400; 1990.
19. 19. Khan, S.; Smith, M. E. Effect of β-endorphin on the contractile responses in mouse skeletal muscle. Muscle Nerve 18:1250-1256; 1995.
20. 20. Nachlas, M. M.; Tsou, K. C.; De Souza, E.; Cheng, C. S.; Seligman, A. M. Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J. Histochem. Cytochem. 5:420-436; 1957.
21. 21. Parry, D. J.; Parslow, H. G. Fibre type susceptibility in the dystrophic mouse. Exp. Neurol. 73:674-685; 1981.
22. 22. Pestronk, A.; Drachman, D. B. A new stain for quantitative measurement of sprouting at neuromuscular junctions. Muscle Nerve 1:70-74; 1978.
23. 23. Richter, E. A.; Hansen, B. F.; Hansen, S. A. Glucose induced insulin resistance of skeletal-muscle glucose transport and uptake. Biochem. J. 252(3):733-737; 1988.
24. 24. Smith, M. E.; Hughes, S. Pro-opiomelanocortin neuropeptide receptors on developing and dystrophic muscle fibres. Mol. Chem. Neuropathol. 19:137-145; 1993.
25. 25. Smith, M. E.; Hughes, S. POMC neuropeptides and their receptors in the neuromuscular system of wobbler mice. J. Neurol. Sci. 124:56-58; 1994.
26. 26. Smith, M. E.; Hughes, S. Effect of β-endorphin and α-melanotropin on muscle wasting in mice. J. Neurol. Sci. 129(Suppl.):127-130; 1995.